Join Growin Stock Community!

Nano-x imaging ltd.NNOX.US Overview

US StockHealthcare
(No presentation for NNOX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NNOX AI Insights

NNOX Overall Performance

NNOX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NNOX Recent Performance

3.59%

Nano-x imaging ltd.

0.05%

Avg of Sector

-0.31%

S&P500

NNOX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NNOX Key Information

NNOX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NNOX Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.

Price of NNOX

NNOX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NNOX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.87
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
12.60
PB Ratio
1.03
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-98.04%
Net Margin
-452.82%
Revenue Growth (YoY)
15.19%
Profit Growth (YoY)
-27.83%
3-Year Revenue Growth
12.24%
3-Year Profit Growth
-36.29%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.87
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
12.60
PB Ratio
1.03
Price-to-FCF
-
Gross Margin
-98.04%
Net Margin
-452.82%
Revenue Growth (YoY)
15.19%
Profit Growth (YoY)
-27.83%
3-Year Revenue Growth
12.24%
3-Year Profit Growth
-36.29%

  • When is NNOX's latest earnings report released?

    The most recent financial report for Nano-x imaging ltd. (NNOX) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NNOX's short-term business performance and financial health. For the latest updates on NNOX's earnings releases, visit this page regularly.

  • What is the operating profit of NNOX?

    According to the latest financial report, Nano-x imaging ltd. (NNOX) reported an Operating Profit of -14.24M with an Operating Margin of -412.97% this period, representing a decline of 0.68% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NNOX's revenue growth?

    In the latest financial report, Nano-x imaging ltd. (NNOX) announced revenue of 3.45M, with a Year-Over-Year growth rate of 13.72%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does NNOX have?

    As of the end of the reporting period, Nano-x imaging ltd. (NNOX) had total debt of 7.88M, with a debt ratio of 0.04. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does NNOX have?

    At the end of the period, Nano-x imaging ltd. (NNOX) held Total Cash and Cash Equivalents of 45.19M, accounting for 0.26 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NNOX go with three margins increasing?

    In the latest report, Nano-x imaging ltd. (NNOX) did not achieve the “three margins increasing” benchmark, with a gross margin of -83.6%%, operating margin of -412.97%%, and net margin of -397%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NNOX's profit trajectory and future growth potential.

  • Is NNOX's EPS continuing to grow?

    According to the past four quarterly reports, Nano-x imaging ltd. (NNOX)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.21. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NNOX?

    Nano-x imaging ltd. (NNOX)'s Free Cash Flow (FCF) for the period is -12.48M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 40.84% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.